Andrew J. Last - Apr 29, 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO BIOB)

Role
EVP, Chief Operating Officer
Signature
/s/ Andrew J. Last
Stock symbol
BIO BIOB
Transactions as of
Apr 29, 2024
Transactions value $
-$98,928
Form type
4
Date filed
4/30/2024, 05:53 PM
Previous filing
Mar 12, 2024
Next filing
Jul 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +1K +19.7% $0.00 6.08K Apr 29, 2024 Direct F1, F2
transaction BIO BIOB Bio-Rad A Common Stock Tax liability -$98.9K -357 -5.87% $277.11 5.72K Apr 29, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -1K -100% $0.00* 0 Apr 29, 2024 Bio-Rad A Common Stock 1K $0.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 9.7660 and 27.5220 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2023 and 03/31/2024, respectively.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.